Grand View Research: Healthcare AI Governance Market to Surge by 2033

Healthcare AI governance platforms are projected to experience rapid market growth through 2033, as regulatory scrutiny and compliance requirements intensify for healthcare providers and technology vendors Grand View Research.

Grand View Research released a comprehensive market analysis on June 10, 2024, forecasting that the global healthcare AI governance market will expand at a compound annual growth rate (CAGR) exceeding 20% through 2033. The report attributes this surge to mounting regulatory oversight, including stricter data privacy, transparency, and algorithmic accountability standards, which are prompting healthcare organizations and technology vendors to invest heavily in AI governance solutions Grand View Research. The analysis covers hospitals, payers, and digital health vendors across North America, Europe, and Asia-Pacific.

Healthcare enterprises face intensifying compliance demands from regulators such as the FDA, HHS, and the European Commission, especially as the EU AI Act and updated HIPAA guidance introduce new obligations for risk management, explainability, and bias mitigation in AI systems European Commission HHS. The Grand View Research report identifies a direct correlation between these regulatory shifts and increased spending on AI governance platforms, which help organizations operationalize compliance, monitor AI model performance, and document decision-making for audits. The report also notes that healthcare providers are prioritizing solutions that support continuous monitoring, automated documentation, and integration with existing risk management frameworks Grand View Research.

CTOs, CISOs, and Compliance Officers in healthcare should expect heightened scrutiny of AI deployments over the next 12-18 months, with regulators likely to demand detailed evidence of risk controls, bias testing, and patient safety monitoring. Organizations should accelerate investments in AI governance platforms that offer robust audit trails, real-time monitoring, and automated compliance reporting. Failure to adapt could result in regulatory penalties, reputational damage, or exclusion from payer networks as compliance standards tighten HHS.

What This Means for Enterprise AI

Healthcare CTOs must prioritize integration of AI governance tools that align with the EU AI Act’s risk management requirements and HIPAA’s evolving privacy mandates. This includes implementing solutions capable of continuous model monitoring, bias detection, and automated documentation to satisfy both internal and external audits European Commission.

CISOs should ensure that AI governance platforms provide granular access controls, incident response workflows, and real-time alerts for anomalous AI behavior, as regulators increasingly expect proactive risk mitigation and transparent reporting Grand View Research.

Compliance Officers must prepare for more frequent and detailed regulatory inquiries, requiring clear evidence of AI system validation, patient safety impact assessments, and ongoing compliance monitoring. Investing in platforms that automate these processes will be critical to maintaining regulatory alignment and avoiding costly enforcement actions HHS.